Bios Capital Management, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Bios Capital Management, Lp disclosed 6 stock positions valued at approximately $41.67M as of quarter-end June 30, 2026. The largest holdings include ACTUATE THERAPEUTICS INC, OPUS GENETICS INC, and COGNITION THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 6
- Portfolio Value
- $41.67M
Holdings by Sector
Bios Capital Management, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS INC | ACTU | Healthcare | 36.90% | 10,049,996 | - | - | $15,376,494 |
| OPUS GENETICS INC | OCUP | Other | 36.33% | 3,683,429 | - | - | $15,138,893 |
| COGNITION THERAPEUTICS INC | CGTX | Healthcare | 16.56% | 6,000,000 | - | - | $6,900,001 |
| REIN THERAPEUTICS INC | ALRN | Healthcare | 7.44% | 2,982,375 | +1,000,000 | +50.44% | $3,101,670 |
| LANTERN PHARMA INC | LTRN | Healthcare | 2.50% | 249,397 | -615,038 | -71.15% | $1,039,985 |
| IN8BIO INC | INAB | Healthcare | 0.27% | 80,957 | -86,848 | -51.76% | $114,149 |
Showing 6 of 6 holdings in the latest reporting period.